Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of DC Vaccine Targeting MG-7 Antigen to Treat Gastric Cancer

NCT04567069 is registered in ClinicalTrials.gov with The Second Hospital of Shandong University as lead sponsor.

NCT NCT04567069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04567069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of DC Vaccine Targeting MG-7 Antigen to Treat Gastric Cancer
Lead sponsor
The Second Hospital of Shandong University
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 30, 2020
Completion date
June 30, 2022
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer